Mirae Asset Global Investments »

Rapt Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $46k 1.3k 33.87

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Palantir Technologies Cl A (PLTR)

View all positions for Mirae Asset Global Investments

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics